InMed Pharmaceuticals's total assets for Q were $10.47M, a decrease of -11.48% from the previous quarter. INM total liabilities were $2.07M for the fiscal quarter, a -20.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.